BRIEF-NeoGenomics Q3 Revenue USD 188 Million Vs. IBES Estimate USD 183.8 Million

Reuters
Oct 28
BRIEF-<a href="https://laohu8.com/S/NEO">NeoGenomics</a> Q3 Revenue USD 188 Million Vs. IBES Estimate USD 183.8 Million

Oct 28 (Reuters) - NeoGenomics Q3 adjusted EBITDA USD 12.2 million.

  • Q3 gross profit USD 80 million
  • Q3 net income USD -27 million
  • Q3 adjusted net income USD 3.6 million
  • Q3 operating expenses USD 107 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10